GT
RGNX icon

Glenmede Trust’s Regenxbio RGNX Stock Holding History

Glenmede Trust’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-436
Closed -$11K – 2024
2020
Q3 		$11K Sell
436
-250
-36% -$8.15K ﹤0.01% 1850
2020
Q2 		$24K Buy
686
+141
+26% +$5.26K ﹤0.01% 1525
2020
Q1 		$21K Hold
545
– – ﹤0.01% 2078
2019
Q4 		$21K Buy
545
+332
+156% +$13.1K ﹤0.01% 2078
2019
Q3 		$7 Sell
213
-20
-9% -$810 ﹤0.01% 2511
2019
Q2 		$11 Hold
233
– – ﹤0.01% 2335
2019
Q1 		$12 Hold
233
– – ﹤0.01% 2295
2018
Q4 		$9 Buy
+233
New +$13.7K ﹤0.01% 2324

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Korea Investment Corp
Korea Investment Corp Seoul, South Korea $48.3B AUM 31.57% 1-Year Est. Return